Abstract:The binding stoichiometry between Cu(II) and the full-length beta-amyloid A beta(l -42) and the oxidation state of copper in the resultant complex were determined by electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) and cyclic voltammetry. The same approach was extended to the copper complexes of A beta(1-16) and A beta(1-28). A stoichiometric ratio of 1:1 was directly observed, and the oxidation state of copper was deduced to be 2+ for all of the complexes, and residues tyrosine-10 and methionine-35 are not oxidized in the A beta(1-42)-Cu(II) complex. The stoichiometric ratio remains the same in the presence of more than a 10-fold excess of Cu(II). Redox potentials of the sole tyrosine residue and the Cu(II) center were determined to be ca. 0.75 and 0.08 V vs Ag/AgCl [or 0.95 and 0.28 V vs normal hydrogen electrode (NHE)], respectively. More importantly, for the first time, the A beta-Cu(I) complex has been generated electrochemically and was found to catalyze the reduction of oxygen to produce hydrogen peroxide. The voltammetric behaviors of the three A beta segments suggest that diffusion of oxygen to the metal center can be affected by the length and hydrophobicity of the A beta peptide. The determination and assignment of the redox potentials clarify some misconceptions in the redox reactions involving A beta and provide new insight into the possible roles of redox metal ions in the Alzheimer's disease (AD) pathogenesis. In cellular environments, the reduction potential of the A beta-Cu(II) complex is sufficiently high to react with antioxidants (e.g., ascorbic acid) and cellular redox buffers (e.g., glutathione), and the A beta-Cu(I) complex produced could subsequently reduce oxygen to form hydrogen peroxide via a catalytic cycle. Using voltammetry, the A beta-Cu(II) complex formed in solution was found to be readily reduced by ascorbic acid. Hydrogen peroxide produced, in addition to its role in damaging DNA, protein, and lipid molecules, can also be involved in the further consumption of antioxidants, causing their depletion in neurons and eventually damaging the neuronal defense system. Another possibility is that A beta-Cu(II) could react with species involved in the cascade of electron transfer events of mitochondria and might potentially sidetrack the electron transfer processes in the respiratory chain, leading to mitochondrial dysfunction.

Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.

Copper ions influence the toxicity of β-amyloid(1–42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer’s disease

The Double-Edged Role of Copper in the Fate of Amyloid Beta in the Presence of Anti-Oxidants.

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure

Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches

Nitration of Amyloid-Β Peptide (1–42) As a Protective Mechanism for the Amyloid-Β Peptide (1–42) Against Copper Ion Toxicity

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

Copper Chelators Promote Nonamyloidogenic Processing of AβPP Via MT1/2/CREB‐dependent Signaling Pathways in AβPP/PS1 Transgenic Mice

Cu2+ Affects Amyloid-\b{eta} (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces

The Role of Copper and the Copper-Related Protein CUTA in Mediating APP Processing and Aβ Generation

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Characterization of Copper Binding to the Peptide Amyloid-Beta(1-16) Associated with Alzheimer'S Disease

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

Cu(II) Enhances the Effect of Alzheimer’s Amyloid-Β Peptide on Microglial Activation

Redox Reactions Of Copper Complexes Formed With Different Beta-Amyloid Peptides And Their Neuropathalogical Relevance

Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer's Disease

A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions

The co-effect of copper and lipid vesicles on Aβ aggregation.